-
Research participation and turnover intention: An exploratory analysis of substance abuse counselors.
Knudsen HK, Ducharme LJ, Roman PM. Research participation and turnover intention: An exploratory analysis of substance abuse counselors. Journal of Substance Abuse Treatment 2007;33(2):211-217.
-
Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs.
Sindelar JL, Olmstead TA, Peirce JM. Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs. Addiction 2007;102(9):1463-1471.
-
Provider perspectives on the impact of COVID-19 on treatment of substance use and opioid use disorders among American Indian and Alaska Native Adults.
Richardson M, Hirchak KA, Bajet K, Brigman M, Shaffer R, Keyes B, Anderson Oliver K, Kropp F, McDonell M, Venner KL, Campbell ANC. Provider perspectives on the impact of COVID-19 on treatment of substance use and opioid use disorders among American Indian and Alaska Native Adults. Frontiers in Public Health 2024;12:1356033.
-
Evaluating tests for cluster-randomized trials with few clusters under generalized linear mixed models with covariate adjustment: A simulation study.
Qui H, Cook AJ, Bobb JF. Evaluating tests for cluster-randomized trials with few clusters under generalized linear mixed models with covariate adjustment: A simulation study. Statistics in Medicine 2024;43(2):201-215.
-
Nurse care management of opioid use disorder treatment after 3 years: A secondary analysis of the PROUD cluster randomized clinical trial.
Lapham GT, Hyun N, Bobb JF, Wartko PD, Matthews AG, Yu O, McCormack J, Lee AK, Liu DS, Samet JH, Zare-Mehrjerdi M, Braciszewski JM, Murphy MT, Amsten JH, Horigian VE, Caldeiro RM, Addis M, Bradley KA. Nurse care management of opioid use disorder treatment after 3 years: A secondary analysis of the PROUD cluster randomized clinical trial. JAMA Network Open 2024;7(11):e2447447.
-
Factors associated with PrEP awareness and use among men who have sex with men who use drugs in the southern United States.
Paschen-Wolff MM, Tross S, Nelson CM, Hatch MA, Meche D, Ertl MM, Wright L, Laschober TC. Factors associated with PrEP awareness and use among men who have sex with men who use drugs in the southern United States. AIDS Care 2024;37(1):21-32.
-
Racial and ethnic differences in long-term outcomes among individuals with opioid use disorder at opioid treatment programs.
Zhu Y, Cousins SJ, Clingan SE, Mooney LJ, Saxon A, Evans EA, Hser Y. Racial and ethnic differences in long-term outcomes among individuals with opioid use disorder at opioid treatment programs. Journal of Racial and Ethnic Health Disparities 2024;13:613-619.
-
Data cleaning and harmonization of clinical trial data: Medication-assisted treatment for opioid use disorder.
Balise RR, Hu M, Calderon AR, Odom GJ, Brandt L, Luo SX, Feaster DJ. Data cleaning and harmonization of clinical trial data: Medication-assisted treatment for opioid use disorder. PLoS ONE 2024;19(11):e0312695.
-
Hospital provider’s perspectives on MOUD initiation and continuation after inpatient discharge.
Shearer R, Englander H, Hagedorn H, Fawole A, Laes J, Titus H, Patten A, Oot E, Appleton N, Fitzpatrick A, Kibben R, Fernando J, McNeely J, Gustafson D, Krawczyk N, Weinstein Z, Baukol P, Ghitza U, Siegler T, Bart G, Bazzi A. Hospital provider's perspectives on MOUD initiation and continuation after inpatient discharge. Journal of General Internal Medicine 2025;40:2926-2933.
-
Pharmacy-based preventive services for opioid use disorder: A survey of U.S. pharmacists.
Wu L, King J, Hefner K, Schactman M, John W, Hagemeier N, Matthews AG, Levitt N, Mannelli P. Pharmacy-based preventive services for opioid use disorder: A survey of U.S. pharmacists. Addiction Science & Clinical Practice 2024;19:88.